27 - 28 February 2023
Vaccines As Tools To Combat Antimicrobial Resistance is due to take place as an in-person meeting on 27–28 February 2023, at Edgbaston Park Hotel and Conference Centre in Birmingham, UK.
COVID-19 demonstrates the devastation of infection when treatment options are limited. The pandemic also demonstrates how vaccines normalise social and economic freedom and equality. Antimicrobial resistance (AMR) has a greater potential to impact our lives.
AMR is a growing global problem, with 1.27 million deaths attributable to AMR bacteria annually. Vaccines can impact AMR by preventing infections and reducing the need for antibiotics which will slow the emergence of AMR.
There are no vaccines, or extant vaccines are sub-optimal, against many human-specific or veterinary/zoonotic bacterial infections. Generating new vaccines for bacterial pathogens is complex. The antigen content, delivery platform and host immune status all influence vaccine development, cost, pathogen evasion and use. Therefore, successful vaccine development requires combined expertise in microbiology (antigen selection), chemistry (platform technology) and host response (immunology). This meeting will address these key areas along the AMR-vaccine platform-veterinary/human immunology axis.
Image credit: iStock/Dr Microbe.
Catrin Moore, Senior Lecturer, St George's University of London, UK
10:00 - 10:30
Mateusz Hasso-Agopsowicz, Technical Officer, WHO, Switzerland
10:30 - 11:00
11:00 - 11:30
Mark Stevens, Chair of Microbial Pathogenesis & Deputy Director, The Roslin Institute, University of Edinburgh, UK
11:30 - 12:00
Hester Nichols, Project Lead, The Vaccine Group Ltd, UK
12:00 - 12:13
Verena Lentsch, PhD student, ETH Zurich, Switzerland
12:13 - 12:26
Rory Hills, Graduate student, University of Oxford, UK
12:26 - 12:39
12:40 - 13:40
Angela Brueggemann, Professor of Infectious Disease Epidemiology, University of Oxford, UK
13:40 - 14:10
Cristina Alaimo, Clinical Director, LimmaTech Biologics, Switzerland
14:10 - 14:23
Sophie Higham, Research Assistant, Imperial College London, UK
14:23 - 14:36
Giuseppe Ercoli, Research Associate, UCL, UK
14:36 - 14:39
Jose Bengoechea, Director, Wellcome Wolfson Institute for Experimental Medicine, Queen's University Belfast, UK
14:50 - 15:20
Suzan HM Rooijakkers, Professor, University Medical Centre Utrecht, The Netherlands
15:20 - 15:50
15:50 - 16:00
16:00 - 16:15
16:15 - 17:30
Camille Locht, Research Director, Inserm / Institut Pasteur de Lille, France
09:00 - 09:30
Caroline Zellmer, PhD student, University of Cambridge, UK
09:30 - 09:43
Omar Rossi, Lab Head serology and immunology, GSK Vaccines Institute for Global Health, Italy
09:43 - 09:56
Francesca Micoli, Senior Project Leader and Director of GVGH Innovation Academy, GSK Vaccines Institute for Global Health, Italy
09:56 - 10:09
Ian Henderson, Executive Director, Institute for Molecular Bioscience, The University of Queensland, Australia
10:10 - 10:40
10:40 - 11:10
Brendan Wren, London School of Hygiene and Tropical Medicine, UK
11:10 - 11:40
Galit Alter, VP Immunology, Moderna, USA
11:40 - 12:10
12:10 - 13:10
Cal MacLennan, BactiVac Network Director, University of Birmingham, UK
13:10 - 13:40
Dr Christine Rollier, Professor of Vaccinology, University of Surrey, UK
13:40 - 14:10
14:10 - 14:40
Adam Dale, NIHR Academic Clinical Lecturer in Infectious Diseases & Medical Microbiology, University of Southampton, UK
14:40 - 15:10
Naina McCann, Clinical Research Fellow / DPhil Student, Oxford Vaccine Group, UK
15:10 - 15:40
Constantino López-Macías, Medical Research Unit on Immunochemistry, National Medical Centre “Siglo XXI”/Mexican Institute for Social Security, Mexico
15:40 - 16:10
Adam Cunningham, BactiVac Network Co-Director, University of Birmingham, UK
16:10 - 16:30
Registration
08:00 - 09:15
Adam Cunningham, BactiVac Network Co-Director, University of Birmimgham, UK Welcome
09:15 - 09:25
Professor Ian MacLennan, Emeritus Professor of Immunology, University of Birmingham, UK Keynote Lecture - Affinity maturation and persistence of antibody responses
09:25 - 10:00
Catrin Moore, Senior Lecturer, St George's University of London, UK Session 1: AMR - the problem in the context of human and veterinary health
10:00 - 10:30
Mateusz Hasso-Agopsowicz, Technical Officer, WHO, Switzerland Session 1: AMR - the problem in the context of human and veterinary health
10:30 - 11:00
Session 1: AMR - the problem in the context of human and veterinary health
11:00 - 11:30
Mark Stevens, Chair of Microbial Pathogenesis & Deputy Director, The Roslin Institute, University of Edinburgh, UK Session 1: AMR - the problem in the context of human and veterinary health
11:30 - 12:00
Hester Nichols, Project Lead, The Vaccine Group Ltd, UK Session 1: AMR - the problem in the context of human and veterinary health
12:00 - 12:13
Verena Lentsch, PhD student, ETH Zurich, Switzerland Session 1: AMR - the problem in the context of human and veterinary health
12:13 - 12:26
Rory Hills, Graduate student, University of Oxford, UK Session 1: AMR - the problem in the context of human and veterinary health
12:26 - 12:39
Session 1: AMR - the problem in the context of human and veterinary health
12:40 - 13:40
Session 1: AMR - the problem in the context of human and veterinary health
12:40 - 13:40
Angela Brueggemann, Professor of Infectious Disease Epidemiology, University of Oxford, UK Session 2: The strengths and gaps in using vaccination to limit AMR
13:40 - 14:10
Cristina Alaimo, Clinical Director, LimmaTech Biologics, Switzerland Session 2: The strengths and gaps in using vaccination to limit AMR
14:10 - 14:23
Sophie Higham, Research Assistant, Imperial College London, UK Session 2: The strengths and gaps in using vaccination to limit AMR
14:23 - 14:36
Giuseppe Ercoli, Research Associate, UCL, UK Session 2: The strengths and gaps in using vaccination to limit AMR
14:36 - 14:39
Jose Bengoechea, Director, Wellcome Wolfson Institute for Experimental Medicine, Queen's University Belfast, UK Session 3: Host responses to different bacterial antigens and vaccines - key lessons learned
14:50 - 15:20
Suzan HM Rooijakkers, Professor, University Medical Centre Utrecht, The Netherlands Session 3: Host responses to different bacterial antigens and vaccines - key lessons learned
15:20 - 15:50
Session 3: Host responses to different bacterial antigens and vaccines - key lessons learned
15:50 - 16:00
Session 3: Host responses to different bacterial antigens and vaccines - key lessons learned
16:00 - 16:15
Session 3: Host responses to different bacterial antigens and vaccines - key lessons learned
16:15 - 17:30
Drinks reception
17:30 - 19:00
Conference Dinner
19:00 - 21:00
Camille Locht, Research Director, Inserm / Institut Pasteur de Lille, France Session 3 continued: Host responses to different bacterial antigens and vaccines - key lessons learned
09:00 - 09:30
Caroline Zellmer, PhD student, University of Cambridge, UK Session 3 continued: Host responses to different bacterial antigens and vaccines - key lessons learned
09:30 - 09:43
Omar Rossi, Lab Head serology and immunology, GSK Vaccines Institute for Global Health, Italy Session 3 continued: Host responses to different bacterial antigens and vaccines - key lessons learned
09:43 - 09:56
Francesca Micoli, Senior Project Leader and Director of GVGH Innovation Academy, GSK Vaccines Institute for Global Health, Italy Session 3 continued: Host responses to different bacterial antigens and vaccines - key lessons learned
09:56 - 10:09
Ian Henderson, Executive Director, Institute for Molecular Bioscience, The University of Queensland, Australia Session 4: Enhancing the use of existing and novel platforms, technologies, adjuvants - the spectre of 'Pathogen X'
10:10 - 10:40
Session 4: Enhancing the use of existing and novel platforms, technologies, adjuvants - the spectre of 'Pathogen X'
10:40 - 11:10
Brendan Wren, London School of Hygiene and Tropical Medicine, UK Session 4: Enhancing the use of existing and novel platforms, technologies, adjuvants - the spectre of 'Pathogen X'
11:10 - 11:40
Galit Alter, VP Immunology, Moderna, USA Session 4: Enhancing the use of existing and novel platforms, technologies, adjuvants - the spectre of 'Pathogen X'
11:40 - 12:10
Session 4: Enhancing the use of existing and novel platforms, technologies, adjuvants - the spectre of 'Pathogen X'
12:10 - 13:10
Session 4: Enhancing the use of existing and novel platforms, technologies, adjuvants - the spectre of 'Pathogen X'
12:10 - 13:10
Cal MacLennan, BactiVac Network Director, University of Birmingham, UK Session 5: The targeting of bacterial pathogens to reduce AMR - addressing unmet needs
13:10 - 13:40
Dr Christine Rollier, Professor of Vaccinology, University of Surrey, UK Session 5: The targeting of bacterial pathogens to reduce AMR - addressing unmet needs
13:40 - 14:10
Session 5: The targeting of bacterial pathogens to reduce AMR - addressing unmet needs
14:10 - 14:40
Adam Dale, NIHR Academic Clinical Lecturer in Infectious Diseases & Medical Microbiology, University of Southampton, UK Session 5: The targeting of bacterial pathogens to reduce AMR - addressing unmet needs
14:40 - 15:10
Naina McCann, Clinical Research Fellow / DPhil Student, Oxford Vaccine Group, UK Session 5: The targeting of bacterial pathogens to reduce AMR - addressing unmet needs
15:10 - 15:40
Constantino López-Macías, Medical Research Unit on Immunochemistry, National Medical Centre “Siglo XXI”/Mexican Institute for Social Security, Mexico Session 5: The targeting of bacterial pathogens to reduce AMR - addressing unmet needs
15:40 - 16:10
Adam Cunningham, BactiVac Network Co-Director, University of Birmingham, UK Session 5: The targeting of bacterial pathogens to reduce AMR - addressing unmet needs
16:10 - 16:30
Below you will find our invited speakers, who will present their work and research at the meeting.
Constantino López-Macías, Medical Research Unit on Immunochemistry/National Medical Centre “Siglo XXI”/Mexican Institute for Social Security, Mexico
Microbial Genomics is pleased to provide the Outstanding Poster Prize to a scientific poster at the ‘Vaccines as tools to combat antimicrobial resistance’ meeting, selected by members of the organising committee, will win a cash prize and be featured on the Microbe Post. All posters displayed at the meeting are automatically entered for the prize.
The BactiVac Network is offering up to 20 travel bursaries, of up to £1,500 GBP each, to support travel and accommodation costs to attend this Focused Meeting on 27 and 28 February 2023. Travel bursary will cover early bird registration fee, travel, accommodation, subsistence and visa costs.
Applicants must be members of BactiVac and currently based in an organisation within an LMIC country. The Network will typically only support one travel bursary from each institution and preference will be given to applicants not previously awarded a BactiVac travel bursary.
The deadline for submitted applications is 4 November 2022 at 12:00 midnight (GMT). Successful applicants will be notified by 30 November 2022.
Learn more and apply for the bursary on the BactiVac website.
For all queries, please contact: [email protected]
Microbiology Society members get heavily subsidised registration fees for Annual Conference, Focused Meetings and other Society events – both online and in-person. Join now to enjoy these discounts and many other opportunities that are designed for microbiologists at all stages of their career.
BactiVac Network members are also eligible to receive a discounted registration rate for this meeting. You should only select this registration rate if you have a current BactiVac membership but are not a Microbiology Society member.
As part of the preparations for Microbiology Society events due to be held in 2023, the Microbiology Society Council has further discussed the implementation of SARS-CoV-2/COVID-19 mitigations and has agreed the following:
The Microbiology Society Council will continue to monitor the situation and update these mitigations as required.
| Ticket | Early bird | Full price |
| Non-member | £230 | £280 |
| Microbiology Society Full member | £130 | £180 |
| BactiVac Network Member | £130 | £180 |
| Microbiology Society Concessionary member | £100 | £140 |
| Microbiology Society Student member | £70 | £90 |
Upon registration, you should receive an automated confirmation email. Please contact [email protected] if after 24 hours this has not been received.
All registration fees must be paid in full before the start of the event. Any outstanding registration fees must be paid before any joining instructions containing information on how to access the event are sent out.
The meeting will take place in Edgbaston Park Hotel and Conference Centre. It is the University of Birmingham’s hotel and is part of the University of Birmingham Group.
Edgbaston Park Hotel and Conference Centre
53 Edgbaston Park Road
Birmingham
B15 2RS
United Kingdom
Edgbaston Park Hotel and Conference centre is an accessible building, with level access to both the buildings and the main conference suite. A lift is available between levels, as part of the conferences takes places on the first floor, and the lift also serves the venue’s hotel accommodation.
Accessible parking bays are available, and should you choose to stay at the hotel itself, accessible bedrooms with adapted en-suite bathrooms are also available: please choose an Adapted Standard room when you book.
When registering for the meeting, please indicate if you have any accessibility requirements, and if staying at the hotel, you should indicate this when you book directly.
Further information can be found on the venue accessibility statement.
Rail: University Station is the closest railway station to the venue, at 0.7 miles away. The station is a few stops from Birmingham New Street, and trains run frequently.
Birmingham New Street is one of the best connected railway terminals in the country and is very close by Rail from Birmingham International Station, which serves the airport.
Attendee’s can plan their journey using National Rail’s Journey Planner tool.
Coach: Birmingham is well connected with coach and bus services from other major cities and towns throughout the UK. The closest bus station to Edgbaston Park Hotel and Conference Centre is Westmere.
Visit the National Express website to book coach tickets.
Car: Birmingham is easily accessible by car. Attendees are encouraged to car-pool where possible.
For sat-nav, use post-code B15 2RS. Please note parking is on a first-come, first-served basis.
Taxi: There are taxi ranks at New Street Station and throughout the city centre. If you hail a cab, you’ll need to pay the driver in cash. The Uber and Ola apps are also available in Birmingham.
The journey to the hotel from the city centre takes around 15 minutes, depending on traffic.
Air: Birmingham International Airport is just a 25-minute drive away. Alternatively, take a train from the airport’s own station and travel to University station, changing at Birmingham New Street.
Edgbaston Park Hotel offer discounted delegate rates for visiting conference attendees.
The given promotional code is valid for reservations for 27 February–1 March 2023 and entitles you to 15% off the best available flexible Bed & Breakfast rate at the time of booking.
You may book by emailing [email protected] or by ringing 0121 414 8888 (Option 1). In either case, please quote your given promotional code. BACTIVAC23
To book your bedroom online, please visit Edgbaston Park Hotel. When booking your room please ensure you select ‘SPECIAL CODES OR RATES’ and apply the promotional code.
Please note that this code is valid for Standard rooms only and the given code must be applied at the time of booking to guarantee the agreed discounted rate. Additional fees are applicable should you wish to upgrade to an Executive or Deluxe Room, subject to availability. All standard rooms have a maximum occupancy of 2 persons per room. Additional camp beds can be provided within all Executives and some Deluxe rooms at a charge of £25.00 per bed. Additional beds must be requested in advance and are subject to availability.
Please note that any bedrooms not reserved by 16 January 2023 will be released back on the system for general resale to the public. Guests will not be able to book using the code after this date but may be able to book at the standard rate if there is availability.
Carbon footprint offsetting
Delegate travel is the biggest contributor to the carbon emissions involved with Focused Meetings, we would therefore like to encourage all delegates to offset their carbon footprint.
A carbon offset is a way to compensate for your emissions by funding an equivalent carbon dioxide saving elsewhere.
You can calculate and offset your carbon footprint from travelling to the meeting by using this carbon calculator, this supports international projects and sustainable development worldwide.